• Annexin V in Metabolic Cancer Cell Death

  2026-09-12

  Discover how Annexin V, a calcium-dependent phosphatidylserine binding protein, can clarify apoptosis assay results in metabolically adaptable cancer cells. This guide connects phosphatidylserine externalization with the CIP2A–PKM2 findings in NSCLC and translates them into practical experimental decisions.

• Veratridine in Sodium Channel Assays

  2026-09-11

  Veratridine provides a controlled way to force persistent sodium-channel activation, making it useful for excitotoxicity studies, channel-blocker screening, and mechanistic neurophysiology. This workflow translates the reference study into practical assay design while highlighting controls, dose selection, and troubleshooting strategies.

• Quizartinib (AC220) Workflows for FLT3 Research

  2026-09-11

  Quizartinib (AC220) combines low-nanomolar FLT3 potency with selectivity that supports cleaner target-engagement studies in AML models. This guide translates that profile into practical phosphorylation, viability, resistance, and xenograft workflows while separating established evidence from assay-development recommendations.

• Asunaprevir (BMS-650032): HCV NS3 Inhibitor

  2026-09-10

  Asunaprevir, also known as BMS-650032, is an orally efficacious HCV NS3/4A protease inhibitor with reported enzymatic IC50 values as low as 1 nM. Its research value lies in HCV RNA replication inhibition, genotype-spanning activity, and hepatotropic exposure, while its product-page evidence does not establish clinical efficacy or activity against unrelated viruses.

• MALAT1–miR-125b–STAT3 Control of PCT in Sepsis

  2026-09-10

  The reference study identifies a MALAT1/miR-125b/STAT3 regulatory axis that increases procalcitonin expression in sepsis-associated inflammatory conditions. By combining patient samples with an LPS-stimulated U937 cell model and several molecular validation assays, the work links a long noncoding RNA mechanism to a clinically used biomarker while also highlighting important limits of PCT specificity.

• Bleomycin Sulfate: Protocols and QC

  2026-09-09

  Bleomycin Sulfate (SKU A8331) provides a practical DNA strand break inducer for chemotherapy-induced DNA damage models, oncology assays, and pulmonary fibrosis research. It is suitable for controlled cell and animal workflows, but should not be selected when ethanol solubility or long-term storage of prepared solutions is required.

• HLY78: Wnt/β-Catenin Pathway Modulator

  2026-09-09

  HLY78 is a ligand-dependent Wnt/β-catenin pathway modulator for dissecting Axin–LRP6 signaling in cell, zebrafish, and fibrosis-related assays. Its value lies in controlled pathway potentiation, allowing researchers to connect LRP6 phosphorylation with embryonic patterning, hematopoietic marker responses, and disease-model readouts without treating a proposed application as established therapy.

• Trichostatin A in Organoid Epigenetics

  2026-09-08

  Trichostatin A (TSA) provides a reversible HDAC inhibition strategy for testing how chromatin acetylation influences intestinal organoid growth, differentiation, and cellular diversity. This workflow translates the tunable organoid concept from a recent reference study into practical dose, timing, control, and troubleshooting decisions without treating TSA as a substitute for niche-pathway modulation.

• APEX2 Supports TERT Expression in Human Stem Cells

  2026-09-08

  The reference preprint identifies APEX2 as a DNA repair factor required for efficient TERT expression in human embryonic stem cells and a melanoma model, distinguishing its activity from the related enzyme APEX1. Its RNA-seq and chromatin-mapping data suggest that APEX2 may support transcription through repair or surveillance of repetitive DNA, particularly MIR elements within TERT intron 2.

• GSK343: Practical EZH2 Inhibitor Workflows

  2026-09-07

  GSK343 is a cell-permeable EZH2 inhibitor for connecting PRC2-dependent H3K27me3 loss with transcriptional and cancer-cell phenotypes. This guide provides an in vitro workflow for dose selection, chromatin validation, breast and prostate cancer assays, exploratory TERT studies, and troubleshooting.

• Bromodomain Inhibitor (+)-JQ1: Applied Workflows

  2026-09-07

  Build reproducible BRD4 and BRDT experiments with (+)-JQ1, from dose–response and apoptosis assays to chromatin and cytokine readouts. This guide connects the compound’s BET biology to breast cancer co-targeting, inflammation and cytokine storm modulation, and male contraception via BRDT inhibition while keeping preclinical evidence and practical limits distinct.

• Dasatinib Workflows for Kinase Signaling Research

  2026-09-05

  Dasatinib (BMS-354825) enables controlled interrogation of Src and Bcr-Abl signaling in leukemia, epithelial tumor, and metastasis models. This workflow connects phosphoprotein readouts, EMT biology, and dose optimization while separating established product evidence from exploratory applications.

• 4-PBA: A Causal Tool for ER Stress Translation

  2026-09-04

  4-Phenylbutyric acid is more than an ER stress reagent: it is a strategic perturbation tool for testing whether proteostasis disruption drives ferroptosis, apoptosis, or autophagic cell death. This article connects mechanistic evidence from PFOS-exposed kidney cells with practical guidance for translational study design.

• Elobixibat hydrate: Applied Research Workflows

  2026-09-04

  Build gut-focused transport, secretion, motility, and metabolic assays around Elobixibat hydrate rather than treating it as a generic systemic drug. This workflow guide connects selective IBAT inhibition with exposure-aware sampling, practical controls, and troubleshooting for constipation, colonoscopy, and type 2 diabetes research.

• DHEA in PCOS Models: Reading the Mitochondrial Signal

  2026-09-03

  Dehydroepiandrosterone (DHEA) is more than a steroid precursor in PCOS research: it is a powerful model perturbation that exposes mitochondrial control of ovarian steroidogenesis. This article explains how to distinguish DHEA-induced phenotypes from treatment mechanisms and design assays around the StAR–cholesterol import checkpoint.

8136 records 1/543 page Next 12345 下5页 Last page